Merz buys out BioForm Medical, makers of Radiesse
Posted on January 5, 2010Wow, that was fast. One prediction – market consolidation – is already coming true.
CnnMoney.com reports that Merz Pharma Group (“Merz”), a privately-held company based in Frankfurt, Germany, is going forward with a buy-out of BioForm Medical, in a $253 million stock deal.
BioForm Medical is the maker of RADIESSE dermal filler. Merz has several fillers used in Europe – but not in the U.S., and is about to come out with a Botox-competitor, named Xeomin.
For patients though, not to worry: Radiesse will still remain in the U.S. marketplace.
BioForm Medical is the maker of RADIESSE dermal filler. Merz has several fillers used in Europe – but not in the U.S., and is about to come out with a Botox-competitor, named Xeomin.
For patients though, not to worry: Radiesse will still remain in the U.S. marketplace.